Lifetime physical activity influences Parkinson's disease progression

被引:0
|
作者
Hu, Yang Cheng [1 ]
Kusters, Cynthia D. J. [1 ,2 ,3 ]
Paul, Kimberly C. [4 ]
Folle, Aline Duarte [1 ]
Zhang, Keren [1 ]
Shih, I. -Fan [1 ]
Keener, Adrienne M. [4 ,5 ]
Bronstein, Jeff M. [4 ]
Ritz, Beate R. [1 ,4 ,6 ]
机构
[1] UCLA, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA
[4] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA USA
[5] VA Greater Los Angeles Healthcare Syst, Parkinsons Dis Res Educ & Clin Ctr, Los Angeles, CA USA
[6] UCLA, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA
关键词
Parkinson's disease; Physical activity; Exercise; Progression; Time-to-event analysis; EXERCISE;
D O I
10.1016/j.parkreldis.2024.107122
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Past studies suggested that Parkinson's disease (PD) patients who engage in physical activity (PA) after diagnosis have slower motor progression. Here, we examine the influence of lifetime PA prior to PD onset on motor, cognitive, and overall functional decline among PD patients. Methods: For 495 participants in the Parkinson's Environment and Gene (PEG) studies, we collected PA-related measures through interviews and quantified these using metabolic equivalents (MET) scores. PD progression was defined as time to a Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) conversion to >= 35 points, Hoehn and Yahr (H&Y) >= 3, and a 4-point decline in Mini-Mental State Examination (MMSE). We used Cox frailty models to estimate hazard ratios and inverse probability weights to account for heterogeneity by enrollment wave and censoring. Results: For PD patients reporting the highest lifetime strenuous MET-h/wk (highest quartile), we estimated a lower HR for time-to-UPDRS-III-conversion (Q4 vs. Q1: HR = 0.56, 95 % CI = [0.36, 0.87]). Additionally, having engaged in any competitive sport also reduced the risk of reaching a UPDRS-III >= 35 points (low vs. none: HR = 0.61, 95 % CI = [0.44, 0.86]; high vs. none: HR = 0.63; 95 % CI = [0.44,0.86]); high levels of sports activities also affected progression on the H&Y scale (high vs. none: HR = 0.73; 95 % CI = [0.46,1.00]). Lifetime PA measures did not affect time-to-MMSE decline. Conclusion: Our study suggests that PD patients who engaged in higher levels of lifetime strenuous PA and competitive sports prior to PD diagnosis experience slower motor and overall functional decline, suggesting that lifetime PA may contribute to a physical reserve advantageous for PD patients.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] FACTORS ASSOCIATED WITH PHYSICAL ACTIVITY IN AUSTRALIANS WITH PARKINSON'S DISEASE
    McGinley, J. L.
    Danoudis, M.
    Bilney, B.
    Morris, M. E.
    Soh, S.
    Higgins, R.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S249 - S249
  • [32] Impact of Falls on Physical Activity in People with Parkinson's Disease
    Hiorth, Ylva Hivand
    Larsen, Jan Petter
    Lode, Kirsten
    Tysnes, Ole-Bjorn
    Godfrey, Alan
    Lord, Sue
    Rochester, Lynn
    Pedersen, Kenn Freddy
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (01) : 175 - 182
  • [33] Dance Is an Accessible Physical Activity for People with Parkinson's Disease
    Emmanouilidis, Sara
    Hackney, Madeleine E.
    Slade, Susan C.
    Heng, Hazel
    Jazayeri, Dana
    Morris, Meg E.
    PARKINSONS DISEASE, 2021, 2021
  • [34] Remote monitoring of physical activity in Veterans with Parkinson's disease
    Waddell, K.
    Wood, S.
    Koganti, S.
    Morley, J.
    MOVEMENT DISORDERS, 2020, 35 : S670 - S670
  • [35] Monitoring disease progression in Parkinson's disease
    Doudet, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, : 72S - 80S
  • [36] Quantification of beta activity with disease progression in EEG recordings in Parkinson's disease patients
    Behrend, C. E.
    Mace, B. E.
    Gauger, L.
    Kolls, B. J.
    Grill, W. M.
    MOVEMENT DISORDERS, 2015, 30 : S31 - S31
  • [37] Predictors of Parkinson's disease progression
    Ritter, S.
    Uitti, R.
    Putzke, J.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S39 - S39
  • [38] Targeting the Progression of Parkinson's Disease
    George, J. L.
    Mok, S.
    Moses, D.
    Wilkins, S.
    Bush, A. I.
    Cherny, R. A.
    Finkelstein, D. I.
    CURRENT NEUROPHARMACOLOGY, 2009, 7 (01) : 9 - 36
  • [39] The clinical progression of Parkinson's disease
    Poewe, Werner
    Mahlknecht, Philipp
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S28 - S32
  • [40] The fear of progression of Parkinson's disease
    Mayer, S.
    Tekampe, E.
    Frank, A.
    Feige, T.
    Reichmann, H.
    Falkenburger, B.
    MOVEMENT DISORDERS, 2021, 36 : S465 - S465